Skip to Content

Hans W. Sollinger, MD, PhD, FACS, Professor of Surgery and founder of Insulete Inc. has been performing pancreatic transplants for the treatment of Type I diabetes for decades. While the surgeries can be successful, they can also have several complications: costs are high, donors are hard to find and patients must endure immune-suppression after receiving the new pancreas. Insulete stands for “insulin obsolete,” since Dr. Sollinger hopes to make daily insulin injections, the only other current therapy for type I diabetes, unnecessary.

Click here to read more about Dr. Sollinger’s quest to eliminate daily insulin injections for patients with diabetes. Copyright © 2016 The Board of Regents of the University of Wisconsin System